Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1132761

registered interest
date	18/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS
house id	1
legislature	25259 pref label House of Commons
question text	What steps he has taken to prepare the NHS for the UK leaving the EU in October 2019.
tabling member constituency	Argyll and Bute
tabling member printed	Brendan O'Hara
uin	911418
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>As a responsible government, we must continue to plan for every scenario. We continue to carefully review the implications of the latest extension to Article 50 on our no deal planning. We are working closely with partners across the health and care system, and stakeholders, to make detailed plans to ensure the continued supply of medicines and medical products and secure the future of our European Union health and care workforce.</p><p /><p /> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 911419 question first answered 18/06/2019 16:37:00 answering member 1585 label Biography information for Stephen Hammond
tabling member	4371 label Biography information for Brendan O'Hara

1132762

registered interest
date	18/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS
house id	1
legislature	25259 pref label House of Commons
question text	What steps he has taken to prepare the NHS for the UK leaving the EU in October 2019.
tabling member constituency	Motherwell and Wishaw
tabling member printed	Marion Fellows
uin	911419
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>As a responsible government, we must continue to plan for every scenario. We continue to carefully review the implications of the latest extension to Article 50 on our no deal planning. We are working closely with partners across the health and care system, and stakeholders, to make detailed plans to ensure the continued supply of medicines and medical products and secure the future of our European Union health and care workforce.</p><p /><p /> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 911418 question first answered 18/06/2019 16:37:00 answering member 1585 label Biography information for Stephen Hammond
tabling member	4440 label Biography information for Marion Fellows

1132764

registered interest
date	18/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	What progress the Government has made on making medical cannabis available to people who need it.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	911421
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The Government acted swiftly to change the law and those patients for whom it is clinically appropriate can be prescribed medicinal cannabis. It is a clinical decision whether to prescribe, and prescriptions of medicinal cannabis are available, and being issued where it is judged clinically appropriate for the patient.</p><p /><p /> answering member constituency West Suffolk answering member printed Matt Hancock question first answered 18/06/2019 16:50:49 answering member 4070 label Biography information for Matt Hancock
tabling member	4623 label Biography information for Tonia Antoniazzi

1132025

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how and by whom medical cannabis was produced in the UK before its legalisation.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	264425
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>Prior to the change of the law on 1 November 2018, only cannabis-based products that had been given a marketing authorisation (product licence) by the medicines regulators, the Medicines and Healthcare products Regulatory Agency (MHRA) or European Medicines Agency could be prescribed. Before issuing a marketing authorisation the MHRA accesses all the available evidence on efficacy and safety arising out of pre-clinical research and clinical trials and evidence and information supplied by the manufacturer. The regulators also inspect the factory where the medicine is to be made, to make sure that supplies will be of a uniformly and consistently high standard.</p><p> </p><p>The following cannabis-based products and related products received a marketing authorisation in the United Kingdom/European Union before 1 November 2018:</p><p> </p><p>- Sativex - (produced by GW Pharmaceuticals) containing tetrahydrocannabinol (THC) and cannabidiol - holds a licence for spasticity in multiple sclerosis; and</p><p>- Nabilone - (multiple manufacturers) which contains a synthetic, non-natural cannabinoid which mimics THC, holds a marketing authorisation for nausea and vomiting caused by chemotherapy.</p><p> </p><p>In addition, Epidiolex (also produced by GW Pharmaceuticals from cannabis) for two severe forms of intractable epilepsy (Lennox-Gastaut Syndrome or Dravet Syndrome), is currently being considered for a marketing authorisation by the European Medicines Agency.</p><p> </p><p>The change in the law allows the prescription, by specialist doctors on the General Medical Council’s Specialist Register, of cannabis-based products that have not been through this rigorous process but that meet certain quality standards in cases where all licensed products have been considered and discounted and it is in the best interest of the patient. It also makes</p><p>it easier and will incentivise further research into the potential health benefits of cannabis-based products and the development of further licensed products for more routine use in the health service.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:31:54 answering member 4455 label Biography information for Seema Kennedy
tabling member	4385 label Biography information for Dr Philippa Whitford

1132026

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anxiety: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of young people (a) attending and (b) not attending university who suffer from anxiety.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	264317
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>Through the Department of Education, we know that the Higher Education Statistics Agency reported that, in 2017/18, 24,815 UK resident entrants to higher education settings disclosed a diagnosed mental health condition such as anxiety. Robust data is not available to determine how much of this increase is down to increased disclosure resulting from reduced stigma, and how much is due to increased prevalence.</p><p>Any disclosure of diagnosed mental health conditions by higher education students to their institution is voluntary. The actual number of university students with diagnosed mental health conditions is therefore unknown.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 18/06/2019 16:41:44 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	308 label Biography information for Mr Jim Cunningham

1132035

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the requirements for primary care networks to engage with the local community will be.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	264406
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">Primary Care Networks (PCNs) are a new way for primary and community service organisations to work together. For PCNs to be successful they will need to work in partnership with local people and the communities they serve. Legal duties which currently apply to NHS service providers - including general practitioner practices - and commissioners around engagement and consultation will continue to be valid for PCNs.</ins></p></ins></p><p><del class="ministerial">NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England.</del></p><p><del class="ministerial">The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.</del></p><p><del class="ministerial">In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.</del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:34:05 question first ministerially corrected 19/06/2019 08:36:30 answering member 4455 label Biography information for Seema Kennedy previous answer version 123829 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	4249 label Biography information for Anne Marie Morris

1132037

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks: Rural Areas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what population exceptions are in place for Primary Care Networks covering large rural and remote areas.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	264408
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>NHS England has allowed rurality as an exception for meeting the definition of a Primary Care Network (PCN). As set out in the Network Contract Direct Enhanced Service (under paragraph 3.2) commissioners may waiver the 30,000-minimum population “where a PCN serves a natural community which has a low population density across a large rural and remote area”.</p><p>Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/network-contract-des-specification-2019-20-v1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/network-contract-des-specification-2019-20-v1.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:30:48 answering member 4455 label Biography information for Seema Kennedy
tabling member	4249 label Biography information for Anne Marie Morris

1132052

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Homeopathy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether representatives of his Department or Agencies attended the London international conference of the Homeopathic Research Institute on 14 - 17 June 2019; if his Department or agencies will make an assessment of the implications for their policies of papers presented at that conference; and if he will make a statement.
tabling member constituency	Bosworth
tabling member printed	David Tredinnick
uin	264321
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>There was no representation made by the Department at this conference. The Department does not maintain a position on any particular complementary or alternative medicine treatments including homeopathy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:33:15 answering member 4455 label Biography information for Seema Kennedy
tabling member	335 label Biography information for David Tredinnick

1132105

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Suicide: Wolverhampton
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of trends in the rate of suicide among men in Wolverhampton; and what steps he is taking to improve mental health services in the West Midlands.
tabling member constituency	Wolverhampton North East
tabling member printed	Emma Reynolds
uin	264388
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The latest update on suicide prevention from the health scrutiny panel at City of Wolverhampton Council (June 2019), shows that 66 deaths were registered as suicides for the period of 2015-17 and 54 of these (82%) were male.</p><p> </p><p>In ‘Making Wolverhampton a Suicide Safer Community: Wolverhampton Suicide Prevention Strategy 2016–2020’, City of Wolverhampton Council has set the following aims to reduce suicides:</p><p> </p><p>- provide a multi-agency approach to suicide prevention across Wolverhampton;</p><p>- raise awareness of suicide, compelling organisations and the community to take positive action;</p><p>- upskill workforces through information and knowledge enabling them to better understand and respond to poor mental wellbeing and suicide ideation;</p><p>- influence services and policies so that suicide prevention is robustly considered and embedded in routine business; and</p><p>- provide a coordinated suicide support offer which can be accessed by services and communities.</p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 18/06/2019 16:42:26 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4077 label Biography information for Emma Reynolds

1132140

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress NHS England has made on developing a commercial framework in relation to the Voluntary Pricing and Access Scheme for branded medicines.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	264409
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England.</p><p>The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.</p><p>In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:39:17 answering member 4455 label Biography information for Seema Kennedy
tabling member	4249 label Biography information for Anne Marie Morris